Intravitreal Anti-vascular Endothelial Growth Factor versus Observation in Acute Central Serous Chorioretinopathy: One-year Results
Sang-Uk Park, Seung-Jun Lee, Moosang Kim
Korean J Ophthalmol. 2014;28(4):306-313.   Published online 2014 Jul 22     DOI: https://doi.org/10.3341/kjo.2014.28.4.306
Citations to this article as recorded by Crossref logo
Pharmacotherapy of Central Serous Chorioretinopathy: A Review of the Current Treatments
Pierluigi Iacono, Lisa Toto, Eliana Costanzo, Monica Varano, Maria Cristina Parravano
Current Pharmaceutical Design.2019; 24(41): 4864.     CrossRef
Central serous chorioretinopathy: Towards an evidence-based treatment guideline
Thomas J. van Rijssen, Elon H.C. van Dijk, Suzanne Yzer, Kyoko Ohno-Matsui, Jan E.E. Keunen, Reinier O. Schlingemann, Sobha Sivaprasad, Giuseppe Querques, Susan M. Downes, Sascha Fauser, Carel B. Hoyng, Felice Cardillo Piccolino, Jay K. Chhablani, Timothy
Progress in Retinal and Eye Research.2019; 73: 100770.     CrossRef
Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser
Maciej Gawęcki, Agnieszka Jaszczuk-Maciejewska, Anna Jurska-Jaśko, Andrzej Grzybowski
Graefe's Archive for Clinical and Experimental Ophthalmology.2017; 255(12): 2299.     CrossRef
The time of resolution and the rate of recurrence in acute central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy: a case–control study
A Ozkaya, Z Alkin, M Ozveren, A T Yazici, M Taskapili
Eye.2016; 30(7): 1005.     CrossRef
Finasteride is effective for the treatment of central serous chorioretinopathy
E Moisseiev, A J Holmes, A Moshiri, L S Morse
Eye.2016; 30(6): 850.     CrossRef
Correspondence
Shorya V. Azad, Brijesh Takkar, Pradeep Sagar
Retina.2016; 36(5): e39.     CrossRef
Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis
H Q Lu, E Q Wang, T Zhang, Y X Chen
Eye.2016; 30(1): 15.     CrossRef
Intravitreal Bevacizumab and Ranibizumab in the Treatment of Acute Central Serous Chorioretihopathy: A Single Center Retrospective Study
Kemal Tekin, Mehmet Ali Sekeroglu, Ali Bulent Cankaya, Mehmet Yasin Teke, Sibel Doguizi, Pelin Yilmazbas
Seminars in Ophthalmology.2016; : 1.     CrossRef
Long-Term follow-up of Standard Photodynamic Therapy with Standardized Small Spot Size for Diffuse Retinal Pigment Epitheliopathy
Alexander Rouvas, Eleni Nikita, Irini Chatziralli, Ioannis Ladas, Aggeliki Androu, Panagiotis Theodossiadis
European Journal of Ophthalmology.2015; 25(3): 229.     CrossRef
Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy
Ju Young Kim, Han Sang Park, Si Yeol Kim
Graefe's Archive for Clinical and Experimental Ophthalmology.2015; 253(12): 2129.     CrossRef